Metabolic myopathies - PubMed (original) (raw)

Metabolic myopathies

Salvatore DiMauro et al. Curr Rheumatol Rep. 2010 Oct.

Abstract

We consider recent developments in disorders affecting three areas of metabolism: glycogen, fatty acids, and the mitochondrial respiratory chain. Among the glycogenoses, new attention has been directed to defects of glycogen synthesis resulting in absence rather than excess of muscle glycogen ("aglycogenosis"). These include defects of glycogen synthetase and defects of glycogenin, the primer of glycogen synthesis. Considerable progress also has been made in our understanding of alterations of glycogen metabolism that result in polyglucosan storage. Among the disorders of lipid metabolism, mutations in the genes encoding two triglyceride lipases acting hand in hand cause severe generalized lipid storage myopathy, one associated with ichthyosis (Chanarin-Dorfman syndrome), the other dominated by juvenile-onset weakness. For the mitochondrial myopathies, we discuss the importance of homoplasmic mitochondrial DNA mutations and review the rapid progress made in our understanding of the coenzyme Q(10) deficiencies, which are often treatable.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mol Genet Metab. 2010 Jul;100(3):251-6 - PubMed
    1. Neurology. 2008 Jul 22;71(4):260-4 - PubMed
    1. Eur J Biochem. 1988 Sep 15;176(2):391-5 - PubMed
    1. Epilepsia. 2009 May;50 Suppl 5:29-36 - PubMed
    1. J Appl Physiol (1985). 2009 May;106(5):1712-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources